troglitazone has been researched along with 4-nitroquinoline-1-oxide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirose, Y; Katayama, M; Kohno, H; Kuno, T; Mori, H; Qiao, Z; Sakata, K; Shibata, T; Sugie, S; Tanaka, T; Yamada, Y; Yoshida, K | 1 |
1 other study(ies) available for troglitazone and 4-nitroquinoline-1-oxide
Article | Year |
---|---|
Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinogens; Chromans; Cyclin D1; Cyclooxygenase 2; DNA-Binding Proteins; Incidence; Isoenzymes; Ligands; Male; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Tongue; Tongue Neoplasms; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2003 |